APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancers

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Genes

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/gcc.10037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection and analysis of β‐catenin mutations in prostate cancer

  2000cited by this paper
• Five human genes encoding F-box proteins: chromosome mapping and analysis in human tumors

  2000cited by this paper
• Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

  2000cited by this paper
• Detection and analysis of beta-catenin mutations in prostate cancer.

  2000cited by this paper
• Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

  1999cited by this paper
• The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.

  1999cited by this paper
• The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro

  1999cited by this paper
• The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell

  1999cited by this paper
• An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin

  1999cited by this paper
• The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

  1999cited by this paper
• A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.

  1998cited by this paper
• β-Catenin Mutations in Human Prostate Cancer

  1998cited by this paper
• Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer

  1998cited by this paper
• Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

  1998cited by this paper
• beta-TrCP is a negative regulator of Wnt/beta-catenin signaling pathway and dorsal axis formation in Xenopus embryos.

  1998cited by this paper
• Beta-catenin mutations in human prostate cancer.

  1998cited by this paper
• Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

  1998cited by this paper
• Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.

  1998cited by this paper
• Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma

  1997cited by this paper
• Stabilization of beta-catenin by genetic defects in melanoma cell lines.

  1997cited by this paper
• Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly

  1996cited by this paper
• Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

  1996cited by this paper
• APC gene mutations in human prostate cancer.

  1996cited by this paper
• Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

  1995cited by this paper
• Allelic loss of chromosome 18q and prognosis in colorectal cancer.

  1994cited by this paper
• State of Adenomatous Polyposis Coli Gene and ras Oncogenes in Japanese Prostate Cancer

  1994cited by this paper
• Molecular diagnosis of familial adenomatous polyposis.

  1993cited by this paper

• βTrCP facilitates MRN complex localization on chromatin to enhance DNA repair

  2025cites this paper
• βTrCP is involved in the localization of the MRN complex on chromatin to enhance DNA damage repair

  2025cites this paper
• Proteasomal Dysfunction in Cancer: Mechanistic Pathways and Targeted Therapies

  2025cites this paper
• Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course

  2024cites this paper
• Beta-Transducin Repeats-Containing Proteins as an Anticancer Target

  2023cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• Targeting Wnt Signaling in Endometrial Cancer

  2021cites this paper
• Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery

  2021cites this paper
• Ubiquitin ligases in cancer: functions and clinical potentials.

  2021cites this paper
• What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment

  2021cites this paper
• The characteristics and roles of β‐TrCP1/2 in carcinogenesis

  2020cites this paper
• Targeting SCF E3 Ligases for Cancer Therapies.

  2020cites this paper
• Regulation of Stem Cells by Cullin-RING Ligase.

  2020cites this paper
• The metastasis suppressor CD82/KAI1 represses the TGF‐β 1 and Wnt signalings inducing epithelial‐to‐mesenchymal transition linked to invasiveness of prostate cancer cells

  2019cites this paper
• The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression

  2019cites this paper
• HnRNPM is a potential mediator of YY1 which promotes EMT in prostate cancer cells

  2019cites this paper
• Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers

  2019cites this paper
• Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer

  2019cites this paper
• A patent review of the ubiquitin ligase system: 2015–2018

  2018cites this paper
• Interpretation of Tongue Squamous Cell Carcinoma via Protein-Protein Interaction Network Construction and Analysis

  2018cites this paper
• An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues

  2018cites this paper
• β‐TrCP upregulates HIF‐1 in prostate cancer cells

  2018cites this paper
• Ubiquitin in Cell-Cycle Regulation and Dysregulation in Cancer

  2017cites this paper
• Modulation of Wnt/β-Catenin Signaling by Chemoprevention

  2017cites this paper
• Genetic association of polymorphisms in AXIN1 gene with clear cell renal cell carcinoma in a Chinese population.

  2017cites this paper
• E3 ubiquitin ligases in cancer and implications for therapies

  2017cites this paper
• Effect of Bioactive Nutriments in Health and Disease: The Role of Epigenetic Modifications

  2017cites this paper
• β-TrCP1 Is a Vacillatory Regulator of Wnt Signaling.

  2017cites this paper
• A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle

  2016cites this paper
• Recent advances in SCF ubiquitin ligase complex: Clinical implications.

  2016cites this paper
• Involvement of F-BOX proteins in progression and development of human malignancies.

  2016cites this paper
• A Model of Selective Advantage for the Efficient Inference of Cancer Clonal Evolution

  2016cites this paper
• Common Dysregulation of Ribosomal Genes Present in Infants with Acute Respiratory Infection of Respiratory Syncytial Virus, Rhinovirus, and Influenza A

  2015cites this paper
• Androgen Signaling Is a Confounding Factor for β-catenin-mediated Prostate Tumorigenesis

  2015cites this paper
• Algorithmic methods to infer the evolutionary trajectories in cancer progression

  2015cites this paper
• Regulation of cancer stem cells by RING finger ubiquitin ligases.

  2014cites this paper
• The role of CD44 in Wnt/β-catenin signaling

  2014influential citation
• Activation of Wnt/β‐catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia

  2014cites this paper
• Circadian gene variants in cancer

  2014cites this paper
• Expression of β-catenin and mesenchymal markers in canine prostatic hyperplasia and carcinoma.

  2014cites this paper
• Molecular docking studies of flavonoids for their inhibition pattern against β-catenin and pharmacophore model generation from experimentally known flavonoids to fabricate more potent inhibitors for Wnt signaling pathway

  2014cites this paper
• The Role of FBXL Subfamily of F-box Proteins in Tumorigenesis

  2014cites this paper
• Genetic and Signaling Pathway Regulations of Tumor-Initiating Cells of the Prostate

  2013cites this paper
• Androgen Action, Wnt Signaling, and Prostate Tumorigenesis

  2013cites this paper
• Deregulation of the COP9 signalosome-cullin-RING ubiquitin-ligase pathway: mechanisms and roles in urological cancers.

  2013cites this paper
• A Glance at the Complexity of Nutrition and the Prostate: Considering Molecular Targets to Unravel the Most Recent Controversy Between Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk

  2013cites this paper
• Axin gene methylation status correlates with radiosensitivity of lung cancer cells

  2013cites this paper
• ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.

  2013cites this paper
• IdentificationofaNovelRoleofZMIZ2ProteininRegulatingthe ActivityoftheWnt/-CateninSignalingPathway * □

  2013cites this paper
• Identification of a Novel Role of ZMIZ2 Protein in Regulating the Activity of the Wnt/β-Catenin Signaling Pathway*

  2013cites this paper
• Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett’s epithelium

  2012cites this paper
• Wnt/β-catenin signalling in prostate cancer

  2012cites this paper
• Mechanism of β-Catenin-mediated Transcriptional Regulation of Epidermal Growth Factor Receptor Expression in Glycogen Synthase Kinase 3 β-inactivated Prostate Cancer Cells*

  2012cites this paper
• Modulation of Wnt/β-catenin signaling pathway by bioactive food components.

  2012cites this paper
• Protein Degradation in Cell Cycle

  2012cites this paper
• The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.

  2012cites this paper
• The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.

  2012cites this paper
• Xenotransplanted Human Prostate Carcinoma (DU145) Cells Develop into Carcinomas and Cribriform Carcinomas: Ultrastructural Aspects

  2012cites this paper
• Coordination of cell growth and division by the ubiquitin-proteasome system.

  2012cites this paper
• Prostate Cancer Progression to Androgen Independent Disease: The Role of the Wnt/β-Catenin Pathway

  2011cites this paper
• Wnt/β-catenin Signaling in Normal and Cancer Stem Cells

  2011cites this paper
• Wnt signaling in prostate development and carcinogenesis.

  2011cites this paper
• INPP4B: the New Kid on the PI3K Block

  2011cites this paper
• The -Catenin Binding Protein ICAT Modulates Androgen Receptor Activity

  2011cites this paper
• BTRC (beta-transducin repeat containing)

  2011cites this paper
• Dysregulation of the Wnt Pathway in Solid Tumors

  2011cites this paper
• Generation and analysis of mouse models of aberrant β-catenin function

  2011influential citation
• A paraptosis-like cell death induced by δ-tocotrienol in human colon carcinoma SW620 cells is associated with the suppression of the Wnt signaling pathway.

  2011cites this paper
• Activation of β-Catenin Signaling in Androgen Receptor–Negative Prostate Cancer Cells

  2011cites this paper
• The beta-catenin binding protein ICAT modulates androgen receptor activity.

  2011cites this paper
• Matriptase-2 and the biological behaviours of prostate cancer cells : a possible role for beta-catenin

  2011cites this paper
• A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303

  2011cites this paper
• Targeting the Wnt pathway in cancer

  2011cites this paper
• The WNT Signaling Pathway and Its Role in Human Solid Tumors

  2011cites this paper
• Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

  2010cites this paper
• Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway.

  2010cites this paper
• β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor

  2010cites this paper
• Axin downregulates TCF-4 transcription via β-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells

  2010cites this paper
• Reduced β-catenin Expression is Associated with Good Prognosis in Astrocytoma

  2010cites this paper
• Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.

  2010cites this paper
• Androgen Receptor Biology in Prostate Cancer

  2010cites this paper
• 5.21 – Ubiquitin-Dependent Protein Degradation

  2010cites this paper
• Ubiquitin-Dependent Protein Degradation

  2010cites this paper
• No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer

  2009cites this paper
• Association Analysis of Wnt Pathway Genes on Prostate-Specific Antigen Recurrence After Radical Prostatectomy

  2009cites this paper
• Mutations in the AXIN1 gene in advanced prostate cancer.

  2009cites this paper
• Unique Effects of Wnt Signaling on Prostate Cancer Cells: Modulation of the Androgen Signaling Pathway by Interactions of the Androgen Receptor Gene and Protein with Key Components of the Canonical Wnt Signaling Pathway

  2009cites this paper
• Wnt signaling: the good and the bad.

  2008cites this paper
• Evaluation of a variant in the transcription factor 7‐like 2 (TCF7L2) gene and prostate cancer risk in a population‐based study

  2008cites this paper
• Sox7 Is an Independent Checkpoint for β-Catenin Function in Prostate and Colon Epithelial Cells

  2008cites this paper
• Análise da expressão dos genes STEAP1 e STEAP2 em adenocarcinomas de próstata por RT-PCR quantitativa em tempo real

  2008cites this paper
• Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer

  2008cites this paper
• Alterations in β‐catenin expression and localization in prostate cancer

  2008cites this paper
• Regulation of the transcription factor p63 by [beta]TrCP

  2008cites this paper
• RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of beta-catenin by interacting with betaTrCP.

  2007cites this paper
• Cytogenetically balanced translocations are associated with focal copy number alterations

  2007influential citation
• Gene therapy approach in prostate cancer cells using an active Wnt signal.

  2007cites this paper
• Inactivation of Apc in the mouse prostate causes prostate carcinoma.

  2007cites this paper
• Somatic mutations of the β‐TrCP gene in gastric cancer

  2007cites this paper
• Tumor-stroma interactions of metastatic prostate cancer cell lines: analyses using microarrays.

  2007cites this paper